Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Citigroup analyst Scott Gruber downgraded Ovintiv Inc. (NYSE:OVV) from Buy to Neutral and raised the price target from $52 to $62. Ovintiv shares closed at $62.08 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. cut the price target for Alumis Inc (NASDAQ:ALMS) from $40 to $25. HC Wainwright & Co. analyst Mitchell S. Kapoor maintained a Buy rating. Alumis shares closed at $24.80 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. raised Calumet, Inc. (NASDAQ:CLMT) price target from $33 to $60. HC Wainwright & Co. analyst Amit Dayal maintained a Buy rating. Calumet shares closed at $32.06 on Friday. See how other analysts view this stock.
- Guggenheim increased price target for Legence Corp. (NASDAQ:LGN) from $68 to $74. Guggenheim analyst Joseph Osha maintained a Buy rating. Legence shares closed at $54.75 on Friday. See how other analysts view this stock.
- B of A Securities raised the price target for Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) from $8 to $9. B of A Securities analyst Jason Zemansky maintained a Buy rating. Rocket Pharmaceuticals shares closed at $3.77 on Friday. See how other analysts view this stock.
- TD Cowen raised United Therapeutics Corporation (NASDAQ:UTHR) price target from $575 to $660. TD Cowen analyst Joseph Thome maintained a Buy rating. United Therapeutics shares closed at $522.83 on Friday. See how other analysts view this stock.
- Baird cut Vontier Corporation (NYSE:VNT) price target from $47 to $43. Baird analyst Robert Mason maintained a Neutral rating. Vontier shares closed at $35.11 on Friday. See how other analysts view this stock.
- Bernstein cut Robinhood Markets, Inc. (NASDAQ:HOOD) price target from $160 to $130. Bernstein analyst Gautam Chhugani maintained an Outperform rating. Robinhood shares closed at $66.03 on Thursday. See how other analysts view this stock.
- Jefferies raised the price target for Expedia Group, Inc. (NASDAQ:EXPE) from $240 to $300. Jefferies analyst John Colantuoni upgraded the stock from Hold to Buy. Expedia shares closed at $225.81 on Friday. See how other analysts view this stock.
- Bernstein cut Coinbase Global, Inc. (NASDAQ:COIN) price target from $440 to $330. Bernstein analyst Gautam Chhugani maintained an Outperform rating. Coinbase shares closed at $161.14 on Friday. See how other analysts view this stock.
Considering buying EXPE stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment